1-10331478-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001365951.3(KIF1B):​c.2925-3042T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.246 in 152,194 control chromosomes in the GnomAD database, including 5,232 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 5232 hom., cov: 32)

Consequence

KIF1B
NM_001365951.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.97

Publications

10 publications found
Variant links:
Genes affected
KIF1B (HGNC:16636): (kinesin family member 1B) Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in chemical synaptic transmission; dense core granule cytoskeletal transport; and vesicle-mediated transport. Predicted to act upstream of or within mitochondrion transport along microtubule. Predicted to be located in cytoplasmic vesicle membrane and neuron projection. Predicted to be part of kinesin complex. Predicted to be active in several cellular components, including axon; dendrite; and microtubule. Implicated in Charcot-Marie-Tooth disease type 2A1; carcinoma (multiple); multiple sclerosis; neuroblastoma; and pheochromocytoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
KIF1B Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease type 2A1
    Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neuroblastoma, susceptibility to, 1
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.307 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365951.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1B
NM_001365951.3
MANE Select
c.2925-3042T>G
intron
N/ANP_001352880.1O60333-1
KIF1B
NM_001365952.1
c.2925-3042T>G
intron
N/ANP_001352881.1O60333-1
KIF1B
NM_015074.3
c.2787-3042T>G
intron
N/ANP_055889.2O60333-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1B
ENST00000676179.1
MANE Select
c.2925-3042T>G
intron
N/AENSP00000502065.1O60333-1
KIF1B
ENST00000377081.5
TSL:1
c.2925-3042T>G
intron
N/AENSP00000366284.1O60333-4
KIF1B
ENST00000377086.5
TSL:1
c.2925-3042T>G
intron
N/AENSP00000366290.1O60333-1

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
37451
AN:
152076
Hom.:
5217
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.113
Gnomad AMI
AF:
0.433
Gnomad AMR
AF:
0.314
Gnomad ASJ
AF:
0.267
Gnomad EAS
AF:
0.283
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.294
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.298
Gnomad OTH
AF:
0.259
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.246
AC:
37501
AN:
152194
Hom.:
5232
Cov.:
32
AF XY:
0.247
AC XY:
18413
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.113
AC:
4704
AN:
41542
American (AMR)
AF:
0.315
AC:
4817
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
926
AN:
3468
East Asian (EAS)
AF:
0.283
AC:
1467
AN:
5184
South Asian (SAS)
AF:
0.250
AC:
1207
AN:
4824
European-Finnish (FIN)
AF:
0.294
AC:
3117
AN:
10588
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.298
AC:
20251
AN:
67974
Other (OTH)
AF:
0.263
AC:
555
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1388
2776
4164
5552
6940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.200
Hom.:
665
Bravo
AF:
0.244
Asia WGS
AF:
0.277
AC:
963
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
15
DANN
Benign
0.66
PhyloP100
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12734551; hg19: chr1-10391536; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.